Compass Pathways logo

CMPS - Compass Pathways Share Price

$35.48 -0.5  -1.3%

Last Trade - 30/07/21

Mid Cap
Market Cap £945.6m
Enterprise Value £817.1m
Revenue £n/a
Position in Universe 2653rd / 7015
Unlock CMPS Revenue
Relative Strength (%)
1m -6.71%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -41.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 0.19
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, COMPASSPathways PLC revenues was not reported. Net loss totaled to$12.7M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CMPS Revenue Unlock CMPS Revenue

Net Income

CMPS Net Income Unlock CMPS Revenue

Normalised EPS

CMPS Normalised EPS Unlock CMPS Revenue

PE Ratio Range

CMPS PE Ratio Range Unlock CMPS Revenue

Dividend Yield Range

CMPS Dividend Yield Range Unlock CMPS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CMPS EPS Forecasts Unlock CMPS Revenue
Profile Summary

COMPASS Pathways PLC is a mental health care company. The Company is focused on developing treatments for people suffering with mental health challenges. It is initially focused on treatment-resistant depression (TRD). It is developing COMP360, a polymorphic crystalline formulation of psilocybin. Its COMP360 psilocybin therapy comprises administration of its COMP360 with psychological support from specially trained therapists with specific professional and educational qualifications. The psilocybin administration session lasts approximately six to eight hours, with patients supported by therapists in a non-directive manner. The psilocybin administration sessions are preceded by preparation sessions, in which patients are given a thorough orientation, and followed by integration sessions to help patients process the range of emotional and physical experiences facilitated by COMP360. The Company is developing COMP360 in conjunction with psychological support in a Phase-IIb trial.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
No. of Shareholders: 39
No. of Employees: 61
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 36,743,886
Free Float (0.0%)
Eligible for
CMPS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CMPS
Upcoming Events for CMPS
Frequently Asked Questions for Compass Pathways
What is the Compass Pathways share price?

As of 30/07/21, shares in Compass Pathways are trading at $35.48, giving the company a market capitalisation of £945.6m. This share price information is delayed by 15 minutes.

How has the Compass Pathways share price performed this year?

Shares in Compass Pathways are currently trading at $35.48 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Compass Pathways price has moved by % over the past year.

What are the analyst and broker recommendations for Compass Pathways?

There are no analysts currently covering Compass Pathways.

When will Compass Pathways next release its financial results?

Compass Pathways is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Compass Pathways dividend yield?

Compass Pathways does not currently pay a dividend.

Does Compass Pathways pay a dividend?

Compass Pathways does not currently pay a dividend.

When does Compass Pathways next pay dividends?

Compass Pathways does not currently pay a dividend.

How do I buy Compass Pathways shares?

To buy shares in Compass Pathways you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Compass Pathways?

Shares in Compass Pathways are currently trading at $35.48, giving the company a market capitalisation of £945.6m.

Where are Compass Pathways shares listed? Where are Compass Pathways shares listed?

Here are the trading details for Compass Pathways:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: CMPS
What kind of share is Compass Pathways?

Based on an overall assessment of its quality, value and momentum, Compass Pathways is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Compass Pathways share price forecast 2021?

Shares in Compass Pathways are currently priced at $35.48. At that level they are trading at 0.101% discount to the analyst consensus target price of 0.00.

Analysts covering Compass Pathways currently have a consensus Earnings Per Share (EPS) forecast of -1.431 for the next financial year.

How can I tell whether the Compass Pathways share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Compass Pathways. Over the past six months, the relative strength of its shares against the market has been -29.7%. At the current price of $35.48, shares in Compass Pathways are trading at -11.07% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Compass Pathways PE Ratio?

We were not able to find PE ratio data for Compass Pathways.

Who are the key directors of Compass Pathways?

We were unable to find the directors for Compass Pathways.

Who are the major shareholders of Compass Pathways?

Here are the top five shareholders of Compass Pathways based on the size of their shareholding:

Thiel (Peter) Individual Investor
Percentage owned: 4.49% (1.79m shares)
Perceptive Advisors LLC Private Equity
Percentage owned: 2% (797k shares)
Victory Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.63% (649k shares)
Founders Fund Venture Capital
Percentage owned: 1.4% (558k shares)
Victory RS Small Cap Growth Fund Mutual Fund
Percentage owned: 0.84% (334k shares)
Similar to CMPS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.